Calibo, Ligaya L.
HRN: 26 16 02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2024
CEFTAZIDIME 1GM (VIAL)
10/31/2024
11/06/2024
IV
1gm
Q8
CAP PTB PULMO MASS
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes